carbamazepine has been researched along with Basal Ganglia Diseases in 11 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tiagabine may cause various mild extrapyramidal side effects." | 5.31 | Transient dystonias in three patients treated with tiagabine. ( Grabowska-Grzyb, A; Wolańczyk, T, 2001) |
| "We report a teenage girl with acute endosulfan poisoning who developed psychosis, generalized tonic-clonic seizures, myoclonic jerks, cortical blindness and limb rigidity." | 3.69 | Selective involvement of basal ganglia and occipital cortex in a patient with acute endosulfan poisoning. ( Gupta, RK; Kaur, A; Pandey, N; Phadke, RV; Pradhan, S; Sharma, K, 1997) |
| "Carbamazepine was switched to its 10-keto analogue oxcarbazepine among six difficult-to-treat schizophrenic or organic psychotic patients using concomitantly haloperidol, chlorpromazine or clozapine." | 2.67 | Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report. ( Huttunen, MO; Lehtovaara, R; Raitasuo, V, 1994) |
| "Weight gain was found to be lower in the elderly for antipsychotic drugs, in particular for olanzapine." | 1.39 | Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland. ( Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T, 2013) |
| "Carbamazepine treatment showed excellent results." | 1.32 | [A case of symptomatic paroxysmal kinesigenic dsykinesia with primary central nervous system lymphoma]. ( Ganser, A; Rollnik, JD; Winkler, T, 2003) |
| "Tiagabine may cause various mild extrapyramidal side effects." | 1.31 | Transient dystonias in three patients treated with tiagabine. ( Grabowska-Grzyb, A; Wolańczyk, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naheed, D | 1 |
| Mehta, S | 1 |
| Goyal, MK | 1 |
| Lal, V | 1 |
| Fuchs, PA | 1 |
| Miller, L | 1 |
| Schiff, M | 1 |
| Greil, W | 1 |
| Häberle, A | 1 |
| Schuhmann, T | 1 |
| Grohmann, R | 1 |
| Baumann, P | 1 |
| Mathur, SK | 1 |
| Saini, M | 1 |
| Bhardwaj, AK | 1 |
| Rollnik, JD | 1 |
| Winkler, T | 1 |
| Ganser, A | 1 |
| Kalra, H | 1 |
| Dalal, PK | 1 |
| Allet, L | 1 |
| Janca, A | 1 |
| Raitasuo, V | 1 |
| Lehtovaara, R | 1 |
| Huttunen, MO | 1 |
| Pradhan, S | 1 |
| Pandey, N | 1 |
| Phadke, RV | 1 |
| Kaur, A | 1 |
| Sharma, K | 1 |
| Gupta, RK | 1 |
| Wolańczyk, T | 1 |
| Grabowska-Grzyb, A | 1 |
| Chouinard, G | 1 |
| Hishikawa, Y | 1 |
| Furuya, E | 1 |
| Yamamoto, J | 1 |
| Nan'no, H | 1 |
2 trials available for carbamazepine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Carbamazepine; Female; Humans; | 1994 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ga | 1988 |
9 other studies available for carbamazepine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Carbamazepine responsive generalized dystonia in Fahr's disease.
Topics: Anticonvulsants; Basal Ganglia Diseases; Calcinosis; Carbamazepine; Dystonia; Female; Humans; Middle | 2017 |
The Use of Carbamazepine to Expedite Metabolism of Risperidone Long-Acting Injection Through Induction of CYP3A4 in a Patient With Extrapyramidal Symptoms.
Topics: Adult; Basal Ganglia Diseases; Carbamazepine; Cytochrome P-450 CYP3A; Delayed-Action Preparations; E | 2018 |
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; An | 2013 |
The lady with a calcified brain.
Topics: Anticonvulsants; Basal Ganglia Diseases; Calcinosis; Calcium; Carbamazepine; Diagnosis, Differential | 2012 |
[A case of symptomatic paroxysmal kinesigenic dsykinesia with primary central nervous system lymphoma].
Topics: Adult; Anticonvulsants; Basal Ganglia; Basal Ganglia Diseases; Brain Neoplasms; Carbamazepine; Chore | 2003 |
Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
Topics: Adult; Anticonvulsants; Antimanic Agents; Basal Ganglia Diseases; Bipolar Disorder; Carbamazepine; D | 2006 |
Selective involvement of basal ganglia and occipital cortex in a patient with acute endosulfan poisoning.
Topics: Adolescent; Anticonvulsants; Basal Ganglia Diseases; Blindness; Carbamazepine; Endosulfan; Female; F | 1997 |
Transient dystonias in three patients treated with tiagabine.
Topics: Acute Disease; Adult; Anticonvulsants; Basal Ganglia Diseases; Carbamazepine; Child; Dose-Response R | 2001 |
Dystonic seizures induced by movement.
Topics: Adolescent; Adult; Athetosis; Basal Ganglia Diseases; Carbamazepine; Child; Chorea; Diagnosis, Diffe | 1973 |